Abstract
Molecular farming is the production of pharmaceutically important and commercially valuable proteins in plants. Its purpose is to provide a safe and inexpensive means for the mass production of recombinant pharmaceutical proteins. Complex mammalian proteins can be produced in transformed plants or transformed plant suspension cells. Plants are suitable for the production of pharmaceutical proteins on a field scale because the expressed proteins are functional and almost indistinguishable from their mammalian counterparts. The breadth of therapeutic proteins produced by plants range from interleukins to recombinant antibodies. Molecular farming in plants has the potential to provide virtually unlimited quantities of recombinant proteins for use as diagnostic and therapeutic tools in health care and the life sciences. Plants produce a large amount of biomass and protein production can be increased using plant suspension cell culture in fermenters, or by the propagation of stably transformed plant lines in the field. Transgenic plants can also produce organs rich in a recombinant protein for its long-term storage. This demonstrates the promise of using transgenic plants as bioreactors for the molecular farming of recombinant therapeutics, including vaccines, diagnostics, such as recombinant antibodies, plasma proteins, cytokines and growth factors.
Similar content being viewed by others
References
An G (1985) High efficiency transformation of cultured tobacco cells. Plant Physiol 79: 568–570.
Arakawa T, Chong DK and Langridge WH (1998a) Efficacy of a food plant-based oral cholera toxin B subunit vaccine [published erratum appears in Nat Biotechnol 1998 16: 478]. Nat Biotechnol 16: 292–297.
Arakawa T, Yu J, Chong K, Hough J, Engen PC and Langridge WH (1998b) A plant-based cholera toxin B subunit-insulin fusion protein protects against the development of autoimmune diabetes. Nat Biotechnol 16: 934–938.
Artsaenko O, Kettig B, Fiedler U, Conrad U and Düring K (1998) Potato tubers as a biofactory for recombinant antibodies. Mol Breeding 4: 313–319.
Artsaenko O, Peisker M, zur Nieden U, Fiedler U, Weiler EW, Müntz K and Conrad U (1995). Expression of a single-chain Fv antibody against abscisic acid creates a wilty phenotype in transgenic tobacco. Plant J 8: 745–750.
Baker D and Harkonen W (1990) Regulatory agency concerns in the manufacturing and testing of monoclonal antibodies for therapeutic use. Targeted Diagn Ther 3: 75–98.
Bardor M, Faye L and Lerouge P (1999) Analysis of the Nglycosylation of recombinant glycoproteins produced in transgenic plants. Trends Plants Sci 4: 376–380.
Barta A, Sommergruber K, Thompson D, Hartmuth K, Matzke M and Matzke A (1986) The expression of a nopaline synthasehuman growth hormone chimaeric gene in transformed tobacco and sunflower callus tissue. Plant Mol Biol 6: 347–357.
Baum TJ, Hiatt A, Parrott WA, Pratt LH and Hussey RS (1996) Expression in tobacco of a functional monoclonal antibody specific to stylet secretions of the root-knot nematode. Mol Plant Microbe In 9: 382–387.
Benvenuto E, Ordas RJ, Tavazza R, Ancora G, Biocca S, Cattaneo A and Galeffi P (1991) 'Phytoantibodies': A general vector for the expression of immunoglobulin domains in transgenic plants. Plant Mol Biol 17: 865–874.
Bisaria V and Panda A (1991) Large-scale plant cell culture: methods, applicatons and products. Curr Opin Biotech 2: 370–374.
Bookman MA (1998) Biological therapy of ovarian cancer: current directions. Semin Oncol 25: 381–396.
Borisjuk NV, Borisjuk LG, Logendra S, Petersen F, Gleba Y and Raskin I (1999) Production of recombinant proteins in plant root exudates. Nat Biotechnol 17: 466–469.
Bosch D, Smal J and Krebber E (1994) A trout growth hormone is expressed, correctly folded and partially glycosylated in the leaves but not the seed of transgenic plants. Transgenic Res 3: 304–310.
Bruyns AM, De Jaeger G, De Neve M, De Wilde C, Van Montagu M and Depicker A (1996) Bacterial and plant-produced scFv proteins have similar antigen-binding properties. FEBS Lett 386: 5–10.
Cabanes-Macheteau M, Fitchette-Laine AC, Loutelier-Bourhis C, Lange C, Vine N, Ma J, et al. (1999) N-Glycosylation of a mouse IgG expressed in transgenic tobacco plants. Glycobiology 9: 365–372.
Carpita N, Sabularse D, Montezinos D and Delmer DP (1979). Determination of the pore size of cell walls of living plant cells. Science 205: 1144–1147.
Carrillo C, Wigdorovitz A, Oliveros JC, Zamorano PI, Sadir AM, Gomez N, et al. (1998) Protective immune response to foot-andmouth disease virus with VP1 expressed in transgenic plants. J Virol 72: 1688–1690.
Chan MT, Chang HH, Ho SL, Tong WF and Yu SM (1993) Agrobacterium-mediated production of transgenic rice plants expressing a chimeric alpha-amylase promoter/beta-glucuronidase gene. Plant Mol Biol 22: 491–506.
Chen MH, Liu LF, Chen YR, Wu HK and Yu SM (1994) Expression of alpha-amylases, carbohydrate metabolism, and autophagy in cultured rice cells is coordinately regulated by sugar nutrient. Plant J 6: 625–636.
Chintalacharuvu KR and Morrison SL (1997) Production of secretory immunoglobulin A by a single mammalian cell. Proc Natl Acad Sci USA 94: 6364–6368.
Christou P (1993) Particle gun-mediated transformation. Curr Opin Biotech 4: 135–141.
Christou P (1996) Transformation technology. Trends Plant Sci 1: 423–431.
Conrad U and Fiedler U (1998). Compartment-specific accumulation of recombinant immunoglobulins in plant cells: An essential tool for antibody production and immunomodulation of physiological functions and pathogen activity. Plant Mol Biol 38: 101–109.
Conrad U, Fiedler U, Artsaenko O and Phillips J (1998) High level and stable accumulation of single chain Fv antibodies in plant storage organs. J Plant Physiol 152: 708–711.
Cramer CL, Weissenborn DL, Oishi KK, Grabau EA, Bennett S, Ponce E, Grabowski GA, and Radin DN (1996) Bioproduction of human enzymes in transgenic tobacco. Ann N Y Acad Sci. 792: 62–71.
Dalsgaard K, Uttenthal A, Jones TD, Xu F, Merryweather A, Hamilton WD, Langeveld JP, Boshuizen RS, Kamstrup S, Lomonossoff GP, Porta C, Vela C, Casal JI, Meloen RH and Rodgers PB (1997) Plant-derived vaccine protects target animals against a viral disease. Nat Biotechnol 15: 248–252.
Daniell T and Edwards R (1995) Changes in protein methylation associated with the elicitation response in cell cultures of alfalfa (Medicago sativa L.). FEBS Lett 360: 57–61.
De Jaeger G, Buys E, Eeckhout D, De Wilde C, Jacobs A, Kapila J, Angenon G, Van Montagu M, Gerats T and Depicker A (1998) High level accumulation of single-chain variable fragments in the cytosol of transgenic Petunia hybrida. Eur J Biochem 259: 1–10.
De Neve M, De Loose M, Jacobs A, Van Houdt H, Kaluza B, Weidle U, Van Montagu M and Depicker A (1993). Assembly of an antibody and its derived antibody fragment in Nicotiana and Arabidopsis. Transgenic Res 2: 227–237.
De Wilde C, De Neve M, De Rycke R, Bruyns AM, De Jaeger G, Van Montagu M, Depicker A and Engler G (1996) Intact antigen-binding MAK33 antibody and Fab fragment accumulate in intercellular spaces of Arabidopsis thaliana. Plant Sci 114: 233–241.
De Zoeten GA, Penswick JR, Horisberger MA, Ahl P, Schultze M and Hohn T (1989) The expression, localization, and effect of a human interferon in plants. Virology 172: 213–222.
Desikan R, Hancock JT, Neill SJ, Coffey MJ and Jones OT (1996) Elicitor-induced generation of active oxygen in suspension cultures of Arabidopsis thaliana. Biochem Soc Trans 24: 199S.
Dieryck W, Pagnier J, Poyart C, Marden MC, Gruber V, Bournat P, et al. (1997) Human haemoglobin from transgenic tobacco [letter]. Nature 386: 29–30.
Düring K, Hippe S, Kreuzaler F and Schell J (1990) Synthesis and selfassembly of a functional monoclonal antibody in transgenic Nicotiana tabacum. Plant Mol Biol 15: 281–293.
Echelard Y (1996) Recombinant protein production in transgenic animals. Curr Opin Biotech 7: 536–540.
Ehsani P, Khabiri A and Domansky NN (1997) Polypeptides of hepatitis B surface antigen produced in transgenic potato. Gene 190: 107–111.
Fahrner RL, Blank GS, and Zapata GA (1999) Expanded bed protein A affinity chromatography of a recombinant humanized monoclonal antibody: Process development, operation, and comparison with a packed bed method. J Biotechnol 75: 273–280.
Fecker L F, Kaufmann A, Commandeur U, Commandeur J, Koenig R and Burgermeister W (1996). Expression of single-chain antibody fragments (scFv) specific for beet necrotic yellow vein virus coat protein or 25kDa protein in Escherichia coli and Nicotiana benthamiana. Plant Mol Biol 32: 979–986.
Fecker LF, Koenig R and Obermeier C (1997) Nicotiana benthamiana plants expressing beet necrotic yellow vein virus (BNYVV) coat protein-specific scFv are partially protected against the establishment of the virus in the early stages of infection and its pathogenic effects in the late stages of infection. Arch Virol 142: 1857–1863.
Fiedler U and Conrad U (1995) High-level production and long-term storage of engineered antibodies in transgenic tobacco seeds. Bio/Technol 13: 1090–1093.
Fiedler U, Philips J, Artsaenko O and Conrad U (1997) Optimisation of scFv antibody production in transgenic plants. Immunotechnology 3: 205–216.
Firek S, Draper J, Owen MR, Gandecha A, Cockburn B and Whitelam GC (1993a) Secretion of a functional single-chain Fv protein in transgenic tobacco plants and cell suspension cultures [published erratum appears in Plant Mol Biol 1994 Mar; 24(5): 833]. Plant Mol Biol 23: 861–870.
Firek S, Draper J, Owen MRL, Gandecha A, Cockburn B and Whitelam GC (1993b) Secretion of a functional single-chain Fv protein in transgenic tobacco plants and cell suspension cultures. Plant Mol Biol 23: 861–870.
Fischer R, Drossard J, Commandeur U, Schillberg S and Emans N (1999a) Toward molecular farming in the future: Moving from diagnostic protein and antibody production in microbes to plants. Biotechnol Appl Biochem 30: 101–108.
Fischer R, Emans N, Schuster F, Hellwig S and Drossard J (1999b) Toward molecular farming in the future: Using plant cell suspension cultures as bioreactors. Biotechnol Appl Biochem. 30: 113–116.
Fischer R, Liao Y-C and Drossard J (1999c) Affinity-purification of a TMV-specific recombinant full-size antibody from a transgenic tobacco suspension culture. J Immunol Meth 226: 1–10.
Fischer R, Schumann D, Zimmermann S, Drossard J, Sack M and Schillberg S (1999d) Expression and characterization of bispecific single chain Fv fragments produced in transgenic plants. European J Biochem 262: 810–816.
Francisco JA, Gawlak SL, Miller M, Bathe J, Russell D, Chace D, et al. (1997) Expression and characterization of bryodin 1 and a bryodin 1-based single-chain immunotoxin from tobacco cell culture. Bioconjug Chem 8: 708–713.
Franconi R, Roggero P, Pirazzi P, Arias FJ, Desiderio A, Bitti O, et al. (1999) Functional expression in bacteria and plants of an scFv antibody fragment against tospoviruses. Immunotechnology 4: 189–201.
Franken E, Teuschel U and Hain R (1997) Recombinant proteins from transgenic plants. Curr Opin Biotech 8: 411–416.
Gallie D 1998. Controlling gene expression in transgenics. Curr Opin Plant Biol 1: 166–172.
Gerstmayer B, Hoffmann M, Altenschmidt U and Wels W (1997) Costimulation of T-cell proliferation by a chimeric B7-antibody fusion protein. Cancer Immunol Immunother 45: 156–158.
Goossens A, Van Montagu M and Angenon G (1999) Cointroduction of an antisense gene for an endogenous seed storage protein can increase expression of a transgene in Arabidopsis thaliana seeds. FEBS Lett 456: 160–164.
Haq TA, Mason HS, Clements JD and Arntzen CJ (1995) Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science 268: 714–716.
Hendy S, Chen ZC, Barker H, Santa Cruz S, Chapman S, Torrance L, Cockburn W and Whitelam GC (1999) Rapid production of single-chain Fv fragments in plants using a potato virus X episomal vector. J Immunol Meth 231: 137–146.
Hiatt A (1990) Antibodies produced in plants. Nature 344: 469–470.
Hiatt A, Cafferkey R and Bowdish K (1989) Production of antibodies in transgenic plants. Nature 342: 76–78.
Hiatt A and Ma JK (1993) Characterization and applications of antibodies produced in plants. Int Rev Immunol 10: 139–152.
Hiatt A, Tang Y, Weiser W and Hein MB (1992) Assembly of antibodies and mutagenized variants in transgenic plants and plant cell cultures. Genet Eng 14: 49–64.
Hiatt AC (1991) Production of monoclonal antibody in plants. Transplant Proc 23: 147–151.
Hiei Y, Komari T and Kubo T (1997) Transformation of rice mediated by Agrobacterium tumefaciens. Plant Mol Biol 35: 205–218.
Hiei Y, Ohta S, Komari T and Kumashiro T (1994) Efficient transformation of rice (Oryza sativa L.) mediated by Agrobacterium and sequence analysis of the boundaries of the T-DNA. Plant J 6: 271–282.
Higo K, Saito Y and Higo H (1993) Expression of a chemically synthesized gene for human epidermal growth factor under the control of cauliflower mosaic virus 35S promoter in transgenic tobacco. Biosci Biotech Biochem 57: 1477–1481.
Hoehl U, Upmeier B and Barz W (1988) Growth and nicotinate biotransformation in batch cultured and airlift fermenter grown soybean cell suspension cultures. Appl Microbiol Biote 28: 319–323.
Hogue RS, Lee JM and An G (1990) Production of a foreign protein product with genetically modified plant cells. Enzyme Microb Technol 12: 533–538.
Hood E, Witcher D, Maddock S, Meyer T, Baszczynski C, Bailey M, et al. (1997) Commercial production of Avidin from transgenic maize: characterization of transformant, production, processing, extraction and purification. Mol Breed 3: 291–306.
Hood EE, Kusnadi A, Nikolov Z and Howard JA (1999) Molecular farming of industrial proteins from transgenic maize. Adv Exp Med Biol 464: 127–147.
Hooker BS, Lee JM and An G (1990) Cultivation of plant cells in a stirred tank reactor. Biotechnol Bioeng 35: 296–304.
Horsch R, Fry JE, Hoffman N, Eicholtz D, Rogers S and Fraley R (1985) A simple and general method for transferring genes into plants. Science 227: 1229–1231.
Johnson J, Lin T and Lomonossoff G (1997) Presentation of heterologous peptides on plant viruses-genetics, structure and function. Ann Rev Phytopathol 35: 67–86.
Kapila J, De Rycke R, van Montagu M and Angenon G (1996) An Agrobacterium mediated transient gene expression system for intact leaves. Plant Sci 122: 101–108.
Kapusta J, Modelska A, Figlerowicz M, Pniewski T, Letellier M, Lisowa O, Yusibov V, Koprowski H, Plucienniczak A and Legocki AB (1999) A plant-derived edible vaccine against hepatitis B virus. FASEB J 13: 1796–1799.
Khoudi H, Laberge S, Ferullo JM, Bazin R, Darveau A, Castonguay Y, Allard G, Lemieux R and Vezina LP (1999) Production of a diagnostic monoclonal antibody in perennial alfalfa plants. Biotechnol Bioeng 64: 135–143.
Kieran PM, MacLoughlin PF and Malone DM (1997) Plant cell suspension cultures: some engineering considerations. J Biotechnol 59: 39–52.
Koehler G and Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256: 495–497.
Koncz C and Schell J (1986) The promoter of TL-DNA gene 5 controls the tissue specific expression of chimeric genes carried by a novel type of Agrobacterium binary vector. Mol Gen Genet 204: 383–396.
Kumagai MH, Donson J, della-Cioppa G and Grill LK (2000) Rapid, high-level expression of glycosylated rice alpha-amylase in transfected plants by an RNA viral vector. Gene 245: 169–174.
Kusnadi AR, Hood EE, Witcher DR, Howard JA and Nikolov ZL (1998) Production and purification of two recombinant proteins from transgenic corn. Biotechnol Prog 14: 149–155.
Kusnadi AR, Nikolov ZL and Howard JA (1997) Production of recombinant proteins in transgenic plants: Practical considerations. Biotechnol Bioeng 56: 473–484.
Larrick JW, Yu L, Chen J, Jaiswal S and Wycoff K (1998) Production of antibodies in transgenic plants. Res Immunol 149: 603–608.
Le Gall F, Bove JM and Garnier M (1998) Engineering of a singlechain variable-fragment (scFv) antibody specific for the stolbur phytoplasma (Mollicute) and its expression in Escherichia coli and tobacco plants. Appl Environ Microbiol 64: 4566–4572.
Lee JS, Choi SJ, Kang HS, Oh WG, Cho KH, Kwon TH, et al. (1997) Establishment of a transgenic tobacco cell suspension culture system for producing murine granulocyte-macrophage colony stimulating factor. Mol Cell 7: 783–787.
Leite A, Kemper E, da Silva M, Luchessi A, Siloto R, Bonaccorsi E, et al. (2000) Expression of correctly processed human growth hormone in seeds of transgenic tobacco plants. Mol Breeding 6: 47–53.
Lindsey K and Jones MGK (1987) Transient gene expression in electroporated protoplasts and intact cells of sugar beet. Plant Mol Biol 10: 43–52.
Long R (1984) Edible tobacco protein. Crops and Soils Magazine. Feb.: 13–15.
Ma J and Hein M (1995a) Immunotherpeuic potential of antibodies produced in plants. Trends Biotechnol 13: 522–527.
Ma J and Hein M (1995b) Plant antibodies for Immunotherapy. Plant Physiol 109: 341–346.
Ma JK, Hiatt A, Hein M, Vine ND, Wang F, Stabila P, et al. (1995) Generation and assembly of secretory antibodies in plants. Science 268: 716–719.
Ma JK, Hikmat BY, Wycoff K, Vine ND, Chargelegue D, Yu L, et al. (1998) Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nat Med 4: 601–606.
Ma JK and Vine ND (1999) Plant expression systems for the production of vaccines. Curr Top Microbiol Immunol 236: 275–292.
Ma JKC, Lehner T, Stabila P, Fux CI and Hiatt A (1994) Assembly of monoclonal antibodies with IgG1 and IgA heavy chain domains in transgenic tobacco plants. Eur J Immunol 24: 131–138.
Ma SW, Zhao DL, Yin ZQ, Mukherjee R, Singh B, Qin HY, et al. (1997) Transgenic plants expressing autoantigens fed to mice to induce oral immune tolerance. Nat Med 3: 793–796.
Magnuson NS, Linzmaier PM, Reeves R, An G, HayGlass K and Lee JM (1998) Secretion of biologically active human interleukin-2 and interleukin-4 from genetically modified tobacco cells in suspension culture. Protein Expr Purif 13: 45–52.
Mariani M and L Tarditi (1992) Validating the preparation of clinical monoclonal antibodies. Bio/Technology 10: 394–396.
Mason HS and CJ Arntzen (1995) Transgenic plants as vaccine production systems. Trends Biotechnol 13: 388–392.
Mason HS, Ball JM, Shi JJ, Jiang X, Estes MK and Arntzen CJ (1996) Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proc Natl Acad Sci USA 93: 5335–5340.
Mason HS, Haq TA, Clements JD and Arntzen CJ (1998) Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene. Vaccine 16: 1336–1343.
Mason HS, Lam DM and Arntzen CJ (1992) Expression of hepatitis B surface antigen in transgenic plants. Proc Natl Acad Sci USA 89: 11745–11749.
Matsumoto S, Ikura K, Ueda M and Sasaki R (1995) Characterisation of a human glycoprotein (erythropoetin) produced in cultured tobacco cells. Plant Mol Biol 27: 1163–1172.
McConnell SJ, Dinh T, Le MH, Brown SJ, Becherer K, Blumeyer K, et al. (1998) Isolation of erythropoietin receptor agonist peptides using evolved phage libraries. Biol Chem 379: 1279–1286.
McCormick AA, Kumagai MH, Hanley K, Turpen TH, Hakim I, Grill LK, et al. (1999) Rapid production of specific vaccines for lymphoma by expression of the tumor-derived single-chain Fv epitopes in tobacco plants. Proc Natl Acad Sci USA 96: 703–708.
McGarvey PB, Hammond J, Dienelt MM, Hooper DC, Fu ZF, Dietzschold B, et al. (1995) Expression of the rabies virus glycoprotein in transgenic tomatoes. Bio/Technology 13: 1484–1487.
Miele L (1997) Plants as bioreactors for pharmaceuticals: regulatory considerations. Trends Biotechnol 15: 45–50.
Modelska A, Dietzschold B, Sleysh N, Fu ZF, Steplewski K, Hooper DC, Koprowski H and Yusibov V (1998) Immunization against rabies with plant-derived antigen. Proc Natl Acad Sci USA 95: 2481–2485.
Moloney MM and Holbrook LA (1997) Subcellular targeting and purification of recombinant proteins in plant production systems. Biotechnol Genet Eng Rev 14: 321–336.
Mu JH, Chua NH and Ross EM (1997) Expression of human muscarinic cholinergic receptors in tobacco. Plant Mol Biol 34: 357–362.
Murano G (1997) FDA perspective on specifications for biotechnology products – from IND to PLA. Dev Biol Stand 91: 3–13.
Murray A, Sekowski M, Spencer DI, Denton G and Price MR (1997) Purification of monoclonal antibodies by epitope and mimotope affinity chromatography. J Chromatogr A 782: 49–54.
Nagata T, Nemoto Y and Seiichiro H (1992) Tobacco BY-2 cell line as the ‘HeLa’ cell in the cell biology of higher plants. Int Rev Cytol 132: 1–30.
Nilsson J, Stahl S, Lundeberg J, Uhlen M and Nygren PA (1997) Affinity fusion strategies for detection, purification, and immobilization of recombinant proteins. Protein Expr Purif 11: 1–16.
Owen M, Gandecha A, Cockburn B and Whitelam G (1992) Synthesis of a functional anti-phytochrome single-chain Fv protein in transgenic tobacco. Bio/Technology 10: 790–794.
Parmenter DL, Boothe JG, van Rooijen GJ, Yeung EC and Moloney MM (1995) Production of biologically active hirudin in plant seeds using oleosin partitioning. Plant Mol Biol 29: 1167–1180.
Phillips J, Artsaencko O, Fiedler U, Horstmann C, Mock HP, Müntz K and Conrad U (1997) Seed-specific immunomodulation of abscisic acid activity induces a developmental switch. EMBO J 16: 4489–4496.
Porceddu A, Falorni A, Ferradini N, Cosentino A, Calcinaro F, Faleri C, et al. (1999) Transgenic plants expressing human glutamic acid decarboxylase (GAD65), a mojor autoantigen in insulin-dependent diabetes mellitus. Mol Breeding 5: 553–560.
Porta C and Lomonossoff GP (1996) Use of viral replicons for the expression of genes in plants. Mol Biotech 5: 209–221.
Porta C, Spall VE, Lin T, Johnson JE and Lomonossoff GP (1996) The development of cowpea mosaic virus as a potential source of novel vaccines. Intervirology 39: 79–84.
Schillberg S, Zimmermann S, Findlay K and R Fischer Plasma membrane display of anti-viral single chain Fv fragments confers resistance to tobacco mosaic virus. Mol. Breeding (in press).
Schillberg S, Zimmermann S, Voss A and Fischer R (1999) Apoplastic and cytosolic expression of full-size antibodies and antibody fragments in Nicotiana tabacum. Transgenic Res 8: 255–263.
Scholthof H, Scholthof K and Jackson A (1996) Plant virus gene vectors for transient expression of foreign proteins in plants. Annu Rev Phytopathol 34: 299–323.
Schouten A, Roosien J, de Boer JM, Wilmink A, Rosso MN, Bosch D, Stiekema WJ, Gommers FJ, Bakker J and Schots A (1997) Improving scFv antibody expression levels in the plant cytosol. FEBS Lett 415: 235–241.
Schouten A, Roosien J, van ngelen FA, de Jong GAM, Borst-Vrenssen AWM, Zilverentant JF, et al. (1996) The C-terminal KDEL sequence increases the expression level of a single-chain antibody designed to be targeted to both cytosol and the secretory pathway in transgenic tobacco. Plant Mol Biol 30: 781–793.
Seki M, Ohzora C, Takeda M and Furusaki S (1997) Taxol (Paclitaxel) production using free and immobilized cells of taxus cuspidata. Biotechnol Bioengng 53: 214–219.
Sheen S (1983) Biomass and chemical composition of tobacco plants under high density growth. Beitr Tabakforsch Int 12: 35–42.
Shen WH and Hohn B (1995) Vectors based on maize streak virus can replicate to high copy numbers in maize plants. J Gen Virol 76: 965–969.
Shin SU, Wright A and Morrison SL (1993) Hybrid antibodies. Int Rev Immunol 10: 177–186.
Sijmons PC, Dekker BMM, Schrammeijer B, Verwoerd TC, van den Elzen PJM and Hoekema A (1990) Production of correctly processed human serum albumin in transgenic plants. Bio/Technol 8: 217–221.
Skerra A (1993) Bacterial expression of immunoglobulin fragments. Curr Opin Biotech 5: 256–262.
Staub J, Garcia B, Graves J, Hajdukiewicz P, Hunter P, Nehra N, Paradkar V, Schlittler M, Carroll J, Spatola L, Ward D, Ye G and Russell D (2000) High-yield production of a human therapeutic protein in tobacco chloroplasts. Nature Biotechnol 18: 333–338.
Stöger E, Vaquero C, Torres E, Sack M, Nicholson L, Drossard J, Williams S, Keen D, Perrin Y, Christou P and Fischer R (2000) Cereal crops as viable production and storage systems for pharmaceutical scFv antibodies. Plant Mol Biol 42: 583–590.
Tackaberry ES, Dudani AK, Prior F, Tocchi M, Sardana R, Altosaar I and Ganz PR (1999) Development of biopharmaceuticals in plant expression systems: cloning, expression and immun ological reactivity of human cytomegalovirus glycoprotein B (UL55) in seeds of transgenic tobacco. Vaccine 17: 3020–3029.
Tacket CO, Mason HS, Losonsky G, Clements JD, Levine MM and Arntzen CJ (1998) Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato. Nat Med 4: 607–609.
Taticek RA, Lee CWT and Shukler ML (1994) Large scale insect and plant cell culture. Curr Opin Biotech 5: 165–174.
Tavladoraki P, Benvenuto E, Trinca S, De Martinis D, Cattaneo A and Galeffi P (1993) Transgenic plants expressing a functional single-chain Fv antibody are specifically protected from virus attack. Nature 366: 469–472.
Terashima M, Murai Y, Kawamura M, Nakanishi S, Stoltz T, Chen L, Drohan W, Rodriguez RL and Katoh S (1999) Production of functional human alpha 1-antitrypsin by plant cell culture. Appl Microbiol Biotechnol 52: 516–523.
Torres E, Vaquero C, Nicholson L, Sack M, Stöger E, Drossard J, et al. (1999) Rice cell culture as an alternative production system for functional diagnostic and therapeutic antibodies. Transgenic Res 8: 441–449.
Turpen TH, Reinl SJ, Charoenvit Y, Hoffman SL, Fallarme V and Grill LK (1995) Malarial epitopes expressed on the surface of recombinant tobacco mosaic virus. Bio/Technology 13: 53–57.
Van Der Heijden R, Verpoorte R and Ten Hoopen HJG (1989) Cell and tissue cultures of Catharanthus-Roseus LG Don a literature survey. Plant Cell Tissue & Organ Culture 18: 231–280.
van Engelen FA, Schouten A, Molthoff JW, Roosien J, Salinas J, Dirkse WG, et al. (1994) Coordinate expression of antibody subunit genes yields high levels of functional antibodies in roots of transgenic tobacco. Plant Mol Biol 26: 1701–1710.
Vaquero C, Sack M, Chandler J, Drossard J, Schuster F, Schillberg S, et al. (1999) Transient expression of a tumor-specific single chain fragment and a chimeric antibody in tobacco leaves. Proc Natl Acad Sci 96: 11128–11133.
Verch T, Lewandowski D and Fischer R (1999) Expression of a single chain antibody in plants using a viral vector (submitted).
Verch T, Yusibov V and Koprowski H (1998) Expression and assembly of a full-length monoclonal antibody in plants using a plant virus vector. J Immunol Meth 220: 69–75.
Verwoerd TC, van Paridon PA, van Ooyen AJJ, van Lent JWM, Hoekema A and Pen J (1995) Stable accumulation of Aspergillus niger phytase in transgenic tobacco leaves. Plant Physiol 109: 1199–1205.
Voss A, Niersbach M, Hain R, Hirsch H, Liao Y, Kreuzaler F, et al. (1995) Reduced virus infectivity in N. tabacum secreting a TMVspecific full size antibody. Mol Breeding 1: 39–50.
Walmsley A and Arntzen C (2000) Plants for delivery of edible vaccines. Curr Opin Biotech 11: 126–129.
Walsh G (1998) Pharmaceuticals, biologics and biopharmaceuticals. In: Biopharmaceuticals: Biochemistry and Biotechnology, (pp. 1–35) Wiley, Chichester, UK.
Whitelam GC, Cockburn B, Gandecha AR and Owen MR (1993) Heterologous protein production in transgenic plants. Biotechnol Genet Eng Rev 11: 1–29.
Whitelam GC, Cockburn W and Owen MR (1994) Antibody production in transgenic plants. Biochem Soc Trans 22: 940–944.
Whitelam GC, aG W (1996) Antibody expression in transgenic plants. Trends Plant Sci 1: 268–271.
Wigdorovitz A, Carrillo C, Dus Santos MJ, Trono K, Peralta A, Gomez MC, et al. (1999) Induction of a protective antibody response to foot and mouth disease virus in mice following oral or parenteral immunization with alfalfa transgenic plants expressing the viral structural protein VP1. Virology 255: 347–353.
Winter G, Griffiths AD, Hawkins RE and Hoogenboom HR (1994) Making antibodies by phage display technology. Annu Rev Immunol 12: 433–455.
Winter G and Milstein C (1991) Man-made antibodies. Nature 349: 293–299.
Witcher D, Hood E, Peterson D, Bailey M, Marchall L, Bond D, et al. (1998) Commercial production of b-glucuronidase (GUS): a model system for the production of proteins in plants. Mol Breeding 4: 301–312.
Worn A, Auf Der Maur A, Escher D, Honegger A, Barberis A and Plückthun A (2000) Correlation between in vitro stability and in vivo performance of anti-GCN4 intrabodies as cytoplasmic inhibitors. J Biol Chem 275: 2795–2803.
Yusibov V, Modelska A, Steplewski K, Agadjanyan M, Weiner D, Hooper DC, et al. (1997) Antigens produced in plants by infection with chimeric plant viruses immunize against rabies virus and HIV-1. Proc Natl Acad Sci USA 94: 5784–5788.
Zeitlin L, Olmsted SS, Moench TR, Co MS, Martinell BJ, Paradkar VM, et al. (1998) A humanized monoclonal antibody produced in transgenic plants for immunoprotection of the vagina against genital herpes. Nat Biotechnol 16: 1361–1364.
Zhong G-Y, Peterson D, Delaney D, Bailey M, Witcher D, Register J, et al. (1999) Commercial production of Aprotinin in transgenic maize seeds. Mol Breeding 5: 345–356.
Zhu Z, Hughes K, Huang L, Sun B, Liu C, Li Y, et al. (1994) Expression of human alpha-interferon in plants. Virology 172: 213–222.
Ziegler M, Thomas S and Danna K (2000) Accumulation of a thermostable endo-1,4-b-D-glucanase in the apoplast of Arabidopsis thaliana leaves. Mol Breeding 6: 37–46.
Zimmermann S, Schillberg S, Liao YC and Fischer R (1998) Intracellular expression of TMV-specific single-chain Fv fragments leads to improved virus resistance in Nicotiana tabacum. Mol Breeding 4: 369–379.
Zwick M, Shen J and Scott J (1998) Phage-displayed peptide libraries. Curr Opin Biotech 9: 427–436.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fischer, R., Emans, N. Molecular farming of pharmaceutical proteins. Transgenic Res 9, 279–299 (2000). https://doi.org/10.1023/A:1008975123362
Issue Date:
DOI: https://doi.org/10.1023/A:1008975123362